查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2017849

美國輸尿管通路鞘套市場：市場規模、佔有率和趨勢分析（按產品類型、適應症、年齡層、尺寸和最終用途分類），細分市場預測（2026-2033 年）

U.S. Ureteral Access Sheath Market Size, Share & Trends Analysis Report By Product Type, By Clinical Indication, By Age Group, By Size, By End-use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

美國輸尿管鞘套市場概述

據估計，2025 年美國輸尿管通路鞘套市值為 1.6034 億美元，預計到 2033 年將達到 2.6619 億美元，2026 年至 2033 年的複合年成長率為 6.5%。

該市場的主要驅動力是尿道結石和其他泌尿系統疾病的日益普遍，這導致美國輸尿管鏡檢查的數量增加。

微創手術日益普及，加之技術進步提高了手術效率和安全性，縮短了手術時間，進一步加速了市場成長。根據美國國家腎臟基金會統計，每年有超過50萬人因腎結石前往急診室就診，凸顯了腎結石給患者帶來的巨大臨床負擔。預計近十分之一的人一生中會在某個階段患上腎結石。

美國輸尿管鞘套市場正經歷顯著成長，這主要得益於腎結石疾病發生率的上升以及微創泌尿系統手術的日益普及。鞘套設計和材料的不斷創新提高了手術的安全性和效率，加速了其在臨床實踐中的應用。此外，完善的醫療基礎設施、有利的保險報銷政策以及泌尿系統手術門診化的趨勢也持續推動市場擴張。

美國泌尿系統協會 (AUA) 2026 年腎結石手術指南預計將推動美國輸尿管鞘套市場成長。輸尿管鏡檢查 (URS) 是一種主要的治療方法，該指南支持在 URS 手術中使用輸尿管鞘套。指引推薦 URS 作為許多腎結石和輸尿管結石的第一線治療方法。這將使輸尿管鞘套（包括具有先進抽吸功能的設計）能夠在 URS 手術中使用，從而加速輸尿管鞘的臨床應用。美國的腎結石手術數量已經很高，而且還在不斷成長，過去十年輸尿管鏡檢查的數量也顯著增加，這導致對輸尿管鞘等介入工具的需求持續旺盛。

尿道結石發生率的上升是輸尿管鞘套市場成長的主要促進因素，因為結石病例的增加直接導致輸尿管鏡檢查數量的增加。輸尿管鞘套在結石治療中至關重要，它能夠實現高效的內視鏡更換並更好地控制腎內壓。隨著生活方式和飲食習慣的改變持續增加腎結石的發生率，對先進輸尿管通路裝置的需求預計將顯著成長。根據美國國家腎臟基金會預測，到2025年，大約十分之一的人一生中會在某個階段患上腎結石。男性罹患腎結石的機率略高於女性，男性患者約為11%，女性患者約為9%。

微創泌尿系統手術的日益普及是輸尿管鞘套市場的主要驅動力，因為這些手術依賴安全有效的輸尿管路徑。在輸尿管鏡檢查、逆行性腎內手術（RIRS）和雷射碎石術等手術中，輸尿管鞘套用於方便器械更換並更好地控制腎內壓。縮短住院時間、減少併發症和加速復原的趨勢進一步推動了對輸尿管鞘套的需求。

技術進步顯著推動了輸尿管鞘套市場的發展，提高了手術的安全性、效率和臨床療效。諸如增強型柔軟性材料、親水性塗層、壓力控制功能和雙腔室設計等創新技術，能夠減少輸尿管損傷並維持最佳的腎內壓。這些進步促進了輸尿管鞘套在複雜泌尿系統手術和微創手術中的廣泛應用。

例如，2025年8月，《台灣醫學會雜誌》報道，尿道結石仍是一種全球流行、經濟負擔沉重且復發率高的疾病。軟性輸尿管鏡（fURS）和高功率鈥雷射（HPHL）技術的進步拓展了其臨床適應症，逆行性腎內手術（RIRS）已成為複雜上尿道結石的首選治療方法。引入帶有扇形輔助抽吸（FANS）的軟性可操控輸尿管鞘套（UAS）能夠有效控制腎內壓，提高結石清除率，並透過最大限度地減少嚴重不利事件進一步改善治療效果。然而，在這些臨床優勢之外，一次性fURS和HPHL系統成本的不斷上漲已成為現代結石治療中一個值得關注的問題。

目錄

第1章：分析方法和範圍

第2章執行摘要

第3章：美國輸尿管鞘套市場：影響因素、趨勢與範圍

  • 市場歷史及展望
  • 市場動態
  • 美國輸尿管鞘套市場：分析工具

第4章：美國輸尿管通路鞘套市場：依產品類型分類的估算與趨勢分析

  • 美國輸尿管通路鞘套市場：依產品類型分類的波動分析
  • 美國輸尿管通路鞘套市場：未來展望（依產品類型分類）
  • 市場規模預測及趨勢分析（2021-2033）
  • 標準型（單流道）
  • 加強型
  • 雙流明

第5章：美國輸尿管通路鞘套市場：依規模分類的估算與趨勢分析

  • 美國輸尿管鞘套市場：按尺寸分類的波動分析
  • 美國輸尿管通路鞘套市場：未來展望（依尺寸分類）
  • 市場規模預測及趨勢分析（2021-2033）
  • 10人或以下
  • 10～12
  • 13-15歲或以上

第6章：美國輸尿管通路鞘套市場：依年齡層別分類的估計與趨勢分析

  • 美國輸尿管通路鞘套市場：依年齡層別分類的波動分析
  • 美國輸尿管通路鞘套市場：未來展望（依年齡層分類）
  • 市場規模預測及趨勢分析（2021-2033）
  • 成人
  • 兒童

第7章：美國輸尿管鞘套市場：依適應症分類的估計與趨勢分析

  • 美國輸尿管通路鞘套市場：按適應症分類的波動分析
  • 美國輸尿管通路鞘套市場：未來展望（依適應症分類）
  • 市場規模預測及趨勢分析（2021-2033）
  • 石材管理
  • 其他

第8章：美國輸尿管通路鞘套市場：依最終用途分類的估算與趨勢分析

  • 美國輸尿管通路鞘套市場：依最終用途分類的波動分析
  • 美國輸尿管通路鞘套市場：未來展望（依最終用途分類）
  • 市場規模預測及趨勢分析（2021-2033）
  • 醫院
  • 專科診所
  • 診斷中心
  • 門診手術中心（ASC）
  • 其他

第9章 競爭情勢

  • 參與企業的分類
  • 市場佔有率分析：依公司分類（2025 年）
  • 主要企業簡介
    • Boston Scientific Corporation
    • BD
    • Olympus
    • Coloplast
    • Cook Medical
    • Advin Health Care
    • ACE Medical Devices
    • Blue Neem Medical Devices Private Limited
    • AMECATH
    • Applied Medical Resources Corporation
    • Volkmann Medizintechnik Gmbh.
    • Urovision-Urotech
    • Rocamed SAM
    • Well Lead Medical Co.,Ltd.
    • Richard Wolf GmbH
    • SCW Medicath Ltd
Product Code: GVR-4-68040-874-0

U.S. Ureteral Access Sheath Market Summary

The U.S. ureteral access sheath market size was estimated at USD 160.34 million in 2025 and is projected to reach USD 266.19 million by 2033, growing at a CAGR of 6.5% from 2026 to 2033. The market is primarily driven by the rising prevalence of urolithiasis and other urological disorders, which have increased the volume of ureteroscopy procedures in the U.S.

The growing adoption of minimally invasive surgeries, coupled with technological advancements that improve procedural efficiency, safety, and reduce operative time, is further accelerating market growth. According to the National Kidney Foundation, more than 500,000 people visit emergency rooms each year due to kidney stones, highlighting the significant clinical burden of the condition. In nearly 1 in 10 individuals, a kidney stone is expected to develop at some point during their lifetime.

The U.S. ureteral access sheath market is experiencing significant growth, driven by the increasing prevalence of kidney stone disease and the widespread adoption of minimally invasive urological procedures. Ongoing innovations in sheath design and materials are improving procedural safety and efficiency, encouraging higher clinical adoption. In addition, strong healthcare infrastructure, favorable reimbursement policies, and the growing shift toward outpatient urology procedures continue to support the market expansion.

The AUA 2026 kidney stone surgery guideline is expected to support the growth of the U.S. ureteral access sheath market. Ureteroscopy (URS) is a key treatment that supports the use of ureteral access sheaths during URS procedures. The guideline recommends URS as a primary treatment option for many kidney and ureteral stones. It allows the use of ureteral access sheaths, including advanced suction-based designs, during URS, thereby increasing clinical adoption of UAS devices. The U.S. already performs a high and growing volume of stone surgeries, with ureteroscopy procedures rising significantly over the last decade, creating sustained procedural demand for access tools such as UAS.

The rising prevalence of urolithiasis is a key driver of growth in the ureteral access sheath market, as increasing stone cases directly increase the number of ureteroscopic procedures. Ureteral access sheaths are essential in stone management, enabling efficient scope exchanges and improved intrarenal pressure control. As kidney stone incidence continues to grow due to lifestyle and dietary changes, demand for advanced ureteral access devices is expected to increase significantly. According to the National Kidney Foundation, in 2025, approximately 1 in 10 people have experienced a kidney stone at some point in their lives. The condition is slightly more common among men, with about 11 out of every 100 affected, compared to around 9 out of every 100 women.

The growing adoption of minimally invasive urological procedures is a key driver of the ureteral access sheath market, as these techniques depend on safe and efficient ureteral access. Procedures such as ureteroscopy, retrograde intrarenal surgery (RIRS), and laser lithotripsy use access sheaths to facilitate smooth instrument exchange and improve intrarenal pressure control. The shift toward shorter hospital stays, reduced complications, and faster recovery continues to accelerate demand for ureteral access sheaths.

Technological advancements are significantly driving the ureteral access sheath market by improving procedural safety, efficiency, and clinical outcomes. Innovations such as enhanced flexible materials, hydrophilic coatings, pressure-controlled and dual-lumen designs reduce ureteral trauma and maintain optimal intrarenal pressure. These developments support wider adoption of ureteral access sheaths across complex and minimally invasive urological procedures.

For instance, in August 2025, the Journal of the Formosan Medical Association reported that urolithiasis remains a prevalent and economically burdensome condition worldwide, with a high recurrence rate. Advances in flexible ureteroscopes (fURS) and high-power holmium laser (HPHL) technologies have broadened clinical indications, positioning retrograde intrarenal surgery (RIRS) as a preferred treatment for complex upper urinary tract stones. The introduction of flexible and navigable suction (FANS) ureteral access sheaths (UAS) has further improved outcomes by enabling effective intrarenal pressure control and high stone-free rates, with minimal serious adverse events. However, alongside these clinical benefits, the rising costs of disposable fURS and HPHL systems are emerging as a significant concern in contemporary stone management.

U.S. Ureteral Access Sheath Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the U.S. ureteral access sheath market report on the basis of product type, size, age group, clinical indication, and end-use:

  • Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Standard (Single-Lumen)
  • Reinforced
  • Dual Lumen
  • Size Outlook (Revenue, USD Million, 2021 - 2033)
  • <10
  • 10 to 12
  • More than or equal to 13 - 15
  • Age Group Outlook (Revenue, USD Million, 2021 - 2033)
  • Adult
  • Pediatric
  • Clinical Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Stone Management
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • ASCs
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Size
    • 1.2.3. Clinical Indication
    • 1.2.4. Age Group
    • 1.2.5. End Use
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Ureteral Access Sheath Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of urolithiasis
      • 3.2.1.2. Growing adoption of minimally invasive urological procedures
      • 3.2.1.3. Technological advancements
      • 3.2.1.4. Increasing procedural volumes in outpatient and ambulatory surgical centers
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced ureteral access sheaths
      • 3.2.2.2. Availability of alternative techniques
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Growing adoption of advanced design
      • 3.2.3.2. Shift toward single-use and disposable devices
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Regulatory and quality compliance requirements
      • 3.2.4.2. Pricing pressure from hospitals and group purchasing organizations
  • 3.3. U.S. Ureteral Access Sheath Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. U.S. Ureteral Access Sheath Market: Product Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Ureteral Access Sheath Market: Product Type Movement Analysis
  • 4.3. U.S. Ureteral Access Sheath Market by Product Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Standard (Single-Lumen)
    • 4.5.1. Standard (Single-Lumen) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Reinforced
    • 4.6.1. Reinforced Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Dual-Lumen
    • 4.7.1. Dual-Lumen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Ureteral Access Sheath Market: Size Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Ureteral Access Sheath Market: Size Movement Analysis
  • 5.3. U.S. Ureteral Access Sheath Market by Size Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. <10
    • 5.5.1. <10 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. 10 to 12
    • 5.6.1. 10 to 12 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. More than or equal to 13 - 15
    • 5.7.1. More than or equal to 13 - 15 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Ureteral Access Sheath Market: Age Group Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Ureteral Access Sheath Market: Age Group Movement Analysis
  • 6.3. U.S. Ureteral Access Sheath Market by Age Group Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Adult
    • 6.5.1. Adult Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Pediatric
    • 6.6.1. Pediatric Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Ureteral Access Sheath Market: Clinical Indication Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Ureteral Access Sheath Market: Clinical Indication Movement Analysis
  • 7.3. U.S. Ureteral Access Sheath Market by Clinical Indication Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. Stone Management
    • 7.5.1. Stone Management Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Ureteral Access Sheath Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Ureteral Access Sheath Market: End Use Movement Analysis
  • 8.3. U.S. Ureteral Access Sheath Market by End Use Outlook (USD Million)
  • 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 8.5. Hospitals
    • 8.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Specialty Clinics
    • 8.6.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Diagnostic Centers
    • 8.7.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Ambulatory Surgery Centers (ASCs)
    • 8.8.1. Ambulatory Surgery Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.9. Others
    • 8.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Shre Analysis, 2025
  • 9.3. Key Company Profiles
    • 9.3.1. Boston Scientific Corporation
      • 9.3.1.1. Company overview
      • 9.3.1.2. Financial performance
      • 9.3.1.3. Product benchmarking
      • 9.3.1.4. Strategic initiatives
    • 9.3.2. BD
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. Olympus
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Coloplast
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Cook Medical
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Advin Health Care
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. ACE Medical Devices
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Blue Neem Medical Devices Private Limited
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. AMECATH
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Applied Medical Resources Corporation
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Volkmann Medizintechnik Gmbh.
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Urovision-Urotech
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. Rocamed SAM
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives
    • 9.3.14. Well Lead Medical Co.,Ltd.
      • 9.3.14.1. Company overview
      • 9.3.14.2. Financial performance
      • 9.3.14.3. Product benchmarking
      • 9.3.14.4. Strategic initiatives
    • 9.3.15. Richard Wolf GmbH
      • 9.3.15.1. Company overview
      • 9.3.15.2. Financial performance
      • 9.3.15.3. Product benchmarking
      • 9.3.15.4. Strategic initiatives
    • 9.3.16. SCW Medicath Ltd
      • 9.3.16.1. Company overview
      • 9.3.16.2. Financial performance
      • 9.3.16.3. Product benchmarking
      • 9.3.16.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. ureteral access sheath, by product type, 2021 - 2033 (USD Million)
  • Table 4 U.S. ureteral access sheath, by size, 2021 - 2033 (USD Million)
  • Table 5 U.S. ureteral access sheath, by age group, 2021 - 2033 (USD Million)
  • Table 6 U.S. ureteral access sheath, by end use, 2021 - 2033 (USD Million)
  • Table 7 U.S. ureteral access sheath, by clinical indication, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 US Ureteral Access Sheath Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 US Ureteral Access Sheat Market, Product Type Outlook Key Takeaways (USD Million)
  • Fig. 12 US Ureteral Access Sheat Market, Product Type Movement Analysis, 2025 & 2033 (USD Million)
  • Fig. 13 Standard (Single-Lumen) Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Reinforced Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Dual-Lumen Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 US Ureteral Access Sheath Market, Size Outlook Key Takeaways (USD Million)
  • Fig. 17 US Ureteral Access Sheath Market Size Movement Analysis, 2025 & 2033 (USD Million)
  • Fig. 18 <10 Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 10 to 12 Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 More than or equal to 13 - 15 Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 US Ureteral Access Sheath Market, Age Group Outlook Key Takeaways (USD Million)
  • Fig. 22 US Ureteral Access Sheath Market Age Group Movement Analysis, 2025 & 2033 (USD Million)
  • Fig. 23 Adult Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Pediatric Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 US Ureteral Access Sheath Market, Clinical Indication Outlook Key Takeaways (USD Million)
  • Fig. 26 US Ureteral Access Sheath Market Clinical Indication Movement Analysis, 2025 & 2033 (USD Million)
  • Fig. 27 Stone Management Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Others Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 US Ureteral Access Sheath Market, End Use Outlook Key Takeaways (USD Million)
  • Fig. 30 US Ureteral Access Sheath Market End Use Movement Analysis, 2025 & 2033 (USD Million)
  • Fig. 31 Hospitals Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Specialty Clinics Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Diagnostic Centers Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Ambulatory Surgery Centers (ASCs) Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Others Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)